ANNOUNCEMENT

MedCity CONVERGE gathers payers, providers, medtech, pharma, digital health, investors, policymakers and more.

Topic: Cincinnati

Vascular disease biopharma Aerpio nabs $27M for trials of diabetic macular edema drug

Vascular disease biopharma Aerpio nabs $27M for trials of diabetic macular edema drug

August 30, 2012 2:33 pm by | 0 Comments

A biopharmaceutical company that spun out of Cincinnati-based Akebia Therapeutics just eight months ago has raised $27 million to support development and clinical trials of its drug for diabetic macular ... Read more
Molina Healthcare to participate in Ohio’s integrated care system for dual eligibles

Molina Healthcare to participate in Ohio’s integrated care system for dual eligibles

August 27, 2012 4:19 pm by | 0 Comments

Molina Healthcare (NYSE: MOH) today announced that its health plan subsidiary, Molina Healthcare of Ohio, Inc., has been chosen to participate in the Southwest (Cincinnati), West Central (Dayton), and Central ... Read more
Cincinnati health IT accelerator names inaugural startup class

Cincinnati health IT accelerator names inaugural startup class

June 5, 2012 5:40 pm by | 0 Comments

A Cincinnati accelerator for health IT startups that models itself on groups like Rock Health, Blueprint Health and Healthbox has named its inaugural class of companies.The startups in the Innov8 ... Read more
Personalized medicine test maker AssureRx raises $12.5M series C round

Personalized medicine test maker AssureRx raises $12.5M series C round

May 30, 2012 4:31 pm by | 0 Comments

Personalized medicine test maker AssureRx Health has raised a $12.5 million series C round of investment that it’ll use to help commercialize its tests that help doctors pick the right ... Read more
A look (kind of) at the first ever, FDA-approved surgical device that can be assembled inside a patient’s body

A look (kind of) at the first ever, FDA-approved surgical device that can be assembled inside a patient’s body

May 11, 2012 8:02 am by | 3 Comments

When the U.S. Food and Drug Administration cleared for the first time a surgical device that can be assembled and disassembled inside a patient’s body, not a lot of people ... Read more
AtriCure targets fourth quarter to begin stroke trial enrollment

AtriCure targets fourth quarter to begin stroke trial enrollment

May 10, 2012 9:46 am by | 0 Comments

Cardiology medical device company AtriCure (NASDAQ:ATRC) is aiming to begin in the fourth quarter a clinical trial investigating its AtriClip device in the treatment of stroke patients.Before that can happen, ... Read more
Meridian Bioscience in midst of clinical trials for two molecular tests

Meridian Bioscience in midst of clinical trials for two molecular tests

April 26, 2012 11:05 am by | 0 Comments

Meridian Bioscience‘s (NASDAQ:VIVO) has two molecular diagnostic tests in clinical trials, with another test expected to begin trials later in the year.Currently in trials are tests built on the company’s ... Read more
Migraine or stroke? Diagnostic test could provide answer

Migraine or stroke? Diagnostic test could provide answer

April 24, 2012 10:59 am by | 0 Comments

Researchers from the University of Cincinnati are behind a startup that’s developing a medical device to help emergency doctors diagnose a severe type of headache that could be a warning ... Read more
Queen City Angels’ chairman testifies before Congress on angel investing

Queen City Angels’ chairman testifies before Congress on angel investing

April 24, 2012 9:30 am by | 0 Comments

Queen City Angels’ Chairman Tony Shipley testified before a House subcommittee last week on the value angel investing brings to the U.S. economy.Shipley represented the Angel Capital Association in making ... Read more
AtriCure CEO Drachman got 64% raise to $1.9M last year

AtriCure CEO Drachman got 64% raise to $1.9M last year

April 13, 2012 4:22 pm by | 0 Comments

AtriCure (Nasdaq:ATRC) CEO David Drachman’s compensation package received a 64 percent boost to $1.9 million last year.The Cincinnati-based cardiac devicemaker paid Drachman about $1.5 million in stock and options and ... Read more
Meridian Bioscience signs molecular diagnostics deal with major GPO

Meridian Bioscience signs molecular diagnostics deal with major GPO

April 13, 2012 10:34 am by | 0 Comments

Meridian Bioscience (NASDAQ:VIVO) has reached a deal to offer discounted prices for two molecular diagnostics tests to members of one of the nation’s largest healthcare group purchasing organizations.Cincinnati-area Meridian hopes ... Read more
Venture fund for aging-related products offers unique benefits to portfolio companies

Venture fund for aging-related products offers unique benefits to portfolio companies

April 12, 2012 9:21 am by | 0 Comments

It’s a cliche in the venture capital industry that VC firms offer much more than money to their portfolio companies.But it’s certainly true that venture firms routinely provide their companies ... Read more
New Medicare innovation project could be ‘game changer’ for primary care

New Medicare innovation project could be ‘game changer’ for primary care

April 11, 2012 1:42 pm by | 1 Comments

A pilot project from the Center for Medicare & Medicaid Innovation will funnel extra cash to primary care practices from both the federal government and private insurers.The federal government has ... Read more
Oral anemia drug meets primary endpoints in phase 2 trial

Oral anemia drug meets primary endpoints in phase 2 trial

April 5, 2012 2:54 pm by | 0 Comments

A once-daily oral anemia drug from Akebia Therapeutics met its primary endpoint in a phase 2a trial of chronic kidney disease patients.The successful 42-day trial of the drug, now called ... Read more
Stroke diagnosis company IschemiaCare planning clinical study

Stroke diagnosis company IschemiaCare planning clinical study

March 28, 2012 9:19 am by | 0 Comments

A startup that’s developing a blood test to diagnose the cause of stroke is planning a clinical study that could pave the way to commercial sales of the test.Cincinnati-based IschemiaCare ... Read more